Reza Radgoodarzi

962 total citations
16 papers, 716 citations indexed

About

Reza Radgoodarzi is a scholar working on Social Psychology, Clinical Psychology and Epidemiology. According to data from OpenAlex, Reza Radgoodarzi has authored 16 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Social Psychology, 5 papers in Clinical Psychology and 5 papers in Epidemiology. Recurrent topics in Reza Radgoodarzi's work include Mental Health Treatment and Access (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Injury Epidemiology and Prevention (4 papers). Reza Radgoodarzi is often cited by papers focused on Mental Health Treatment and Access (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Injury Epidemiology and Prevention (4 papers). Reza Radgoodarzi collaborates with scholars based in Iran and United States. Reza Radgoodarzi's co-authors include Masoumeh Amin‐Esmaeili, Seyed Abbas Motevalian, Vandad Sharifi‎, Mitra Hefazi, Afarin Rahimi‐Movaghar, Ahmad Hajebi, Ramin Mojtabai, Seyed Mohammad Assadi, Vafa Rahimi‐Movaghar and Behrang Shadloo and has published in prestigious journals such as Addiction, Drug and Alcohol Dependence and Addictive Behaviors.

In The Last Decade

Reza Radgoodarzi

16 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reza Radgoodarzi Iran 11 257 208 201 158 116 16 716
Mitra Hefazi Iran 11 260 1.0× 209 1.0× 213 1.1× 184 1.2× 122 1.1× 22 707
João Mazzoncini de Azevedo Marques Brazil 14 280 1.1× 147 0.7× 168 0.8× 82 0.5× 205 1.8× 64 791
Master Textbook 6 201 0.8× 121 0.6× 204 1.0× 190 1.2× 182 1.6× 39 748
Pedro Zitko Chile 16 210 0.8× 209 1.0× 84 0.4× 136 0.9× 229 2.0× 49 813
Christine Hassler France 17 469 1.8× 107 0.5× 178 0.9× 103 0.7× 161 1.4× 33 955
William Gnam Canada 14 528 2.1× 122 0.6× 278 1.4× 152 1.0× 243 2.1× 24 1.1k
Amy James United States 10 514 2.0× 220 1.1× 175 0.9× 143 0.9× 121 1.0× 15 983
Chad D. Morris United States 19 357 1.4× 188 0.9× 169 0.8× 252 1.6× 214 1.8× 35 1.3k
Rita Vandivort-Warren United States 13 127 0.5× 154 0.7× 305 1.5× 175 1.1× 302 2.6× 22 732
Misato Gbedemah United States 16 269 1.0× 159 0.8× 229 1.1× 164 1.0× 199 1.7× 17 1.1k

Countries citing papers authored by Reza Radgoodarzi

Since Specialization
Citations

This map shows the geographic impact of Reza Radgoodarzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Radgoodarzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Radgoodarzi more than expected).

Fields of papers citing papers by Reza Radgoodarzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Radgoodarzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Radgoodarzi. The network helps show where Reza Radgoodarzi may publish in the future.

Co-authorship network of co-authors of Reza Radgoodarzi

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Radgoodarzi. A scholar is included among the top collaborators of Reza Radgoodarzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Radgoodarzi. Reza Radgoodarzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hajebi, Ahmad, Seyed Abbas Motevalian, Afarin Rahimi‐Movaghar, et al.. (2018). Major anxiety disorders in Iran: prevalence, sociodemographic correlates and service utilization. BMC Psychiatry. 18(1). 261–261. 53 indexed citations
2.
Amin‐Esmaeili, Masoumeh, Mitra Hefazi, Reza Radgoodarzi, et al.. (2017). Out-of-pocket cost of drug abuse consequences: results from the Iranian National Mental Health Survey. Eastern Mediterranean Health Journal. 23(3). 150–160. 2 indexed citations
3.
Amin‐Esmaeili, Masoumeh, Afarin Rahimi‐Movaghar, Vandad Sharifi‎, et al.. (2017). Alcohol use disorders in Iran: Prevalence, symptoms, correlates, and comorbidity. Drug and Alcohol Dependence. 176. 48–54. 47 indexed citations
4.
Saadat, Soheil, Nima Hafezi‐Nejad, Afarin Rahimi‐Movaghar, et al.. (2016). Incidence of fall-related injuries in Iran: A population-based nationwide study. Injury. 47(7). 1404–1409. 16 indexed citations
5.
Khalagi, Kazem, Mohammad Alì Mansournia, Afarin Rahimi‐Movaghar, et al.. (2016). Assessing measurement error in surveys using latent class analysis: application to self-reported illicit drug use in data from the Iranian Mental Health Survey. Epidemiology and Health. 38. e2016013–e2016013. 1 indexed citations
6.
Amin‐Esmaeili, Masoumeh, Afarin Rahimi‐Movaghar, Vandad Sharifi‎, et al.. (2016). Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 111(10). 1836–1847. 184 indexed citations
7.
Shadloo, Behrang, Seyed Abbas Motevalian, Vafa Rahimi‐Movaghar, et al.. (2016). Psychiatric Disorders Are Associated with an Increased Risk of Injuries: Data from the Iranian Mental Health Survey (IranMHS).. PubMed. 45(5). 623–35. 24 indexed citations
8.
Tarrahi, Mohammad Javad, Afarin Rahimi‐Movaghar, Hojjat Zeraati, et al.. (2015). Latent Class Analysis of DSM-5 Criteria for Opioid Use Disorders: Results from the Iranian National Survey on Mental Health. European Addiction Research. 21(3). 144–152. 10 indexed citations
9.
Hafezi‐Nejad, Nima, Afarin Rahimi‐Movaghar, Seyed Abbas Motevalian, et al.. (2015). Population-based incidence and cost of non-fatal injuries in Iran: a consistent under-recognized public health concern. Public Health. 129(5). 483–492. 6 indexed citations
10.
Sharifi‎, Vandad, Masoumeh Amin‐Esmaeili, Ahmad Hajebi, et al.. (2015). Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011.. PubMed. 18(2). 76–84. 195 indexed citations
11.
Hafezi‐Nejad, Nima, Afarin Rahimi‐Movaghar, Seyed Abbas Motevalian, et al.. (2014). A nationwide population-based study on incidence and cost of non-fatal injuries in Iran. Injury Prevention. 20(5). e9–e9. 8 indexed citations
12.
Rahimi‐Movaghar, Afarin, Masoumeh Amin‐Esmaeili, Vandad Sharifi‎, et al.. (2014). Iranian mental health survey: design and field proced.. PubMed. 9(2). 96–109. 53 indexed citations
13.
Amin‐Esmaeili, Masoumeh, Seyed Abbas Motevalian, Afarin Rahimi‐Movaghar, et al.. (2014). The translation and psychometric assessment of the persian version of the sheehan disability scale.. PubMed. 9(3). 125–32. 17 indexed citations
14.
Tarrahi, Mohammad Javad, Afarin Rahimi‐Movaghar, Hojjat Zeraati, et al.. (2013). Agreement between DSM-IV and ICD-10 criteria for opioid use disorders in two Iranian samples. Addictive Behaviors. 39(3). 553–557. 3 indexed citations
15.
Hajebi, Ahmad, Seyed Abbas Motevalian, Masoumeh Amin‐Esmaeili, et al.. (2011). Telephone versus face-to-face administration of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, for diagnosis of psychotic disorders. Comprehensive Psychiatry. 53(5). 579–583. 36 indexed citations
16.
Assadi, Seyed Mohammad, et al.. (2003). Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]. BMC Psychiatry. 3(1). 16–16. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026